US EditionWuXi Biologics announces Virogen and VISEN manufacturing projects at new Chengdu facility
Summary by BioProcess International
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
WuXi Biologics announces Virogen and VISEN manufacturing projects at new Chengdu facility
The CDMO announces strategic partnerships with Virogen Biotechnology for VG712 manufacturing and VISEN Pharmaceuticals for lonapegsomatropin production, strengthening its position in advanced biologics manufacturing.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
